Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...

A brief overview of the pathophysiology, diagnosis, and treatment of heparin-induced thrombocytopenia (HIT) is discussed. Following any exposure to unfractionated heparin or low-molecular-weight ...

Low-molecular-weight heparin (LMWH). Your doctor can also give ... IVC filter if your risk for pulmonary embolism goes down. For example, you may be able to start taking blood thinners.

Small molecules are low molecular weight molecules that include lipids ... illustrating a natural example of a molecular glue. α-GalCer is a prototypical antigen recognized by NKT cells, which ...

Diagnosis relies on Doppler ultrasound and pathological assessment. Close monitoring and potential low-molecular-weight heparin (LMWH) therapy aim to prolong gestation and improve outcomes, but debate ...

Low-molecular-weight heparin (LMWH) is the drug of choice in pregnant women requiring prophylaxis or treatment for venous thrombosis. However, the optimal dose with respect to efficacy and safety is ...